US and Australian Researchers Form Alliance to Facilitate Development of Treatments for Childhood Cancers

the ONA take:

Researchers and children's cancer advocates from the United States and Australia formed the Children's Oncology Drug Alliance (CODA), a unique research and development alliance dedicated to the development of treatments for neuroblastoma in children. Neuroblastoma is the most common and fatal form of solid tumor in infants. CODA brings together the resources of the University of New South Wales, NewSouth Innovations, The Kids' Cancer Project, and Novogen from Australia, and Nationwide Children's Hospital in Columbus, Ohio. Its mission is to accelerate development of a new therapeutic approach to neuroblastoma. Clinical trials are due to start in the United States and Australia next year.

US and Australian Researchers Form Alliance to Facilitate Development of Treatments for Childhood Ca
US and Australian Researchers Form Alliance to Facilitate Development of Treatments for Childhood Ca
Alliance of Australian and U.S. researchers and children's cancer advocates focused on developing drugs as potential treatments for neuroblastoma, the most common solid form of childhood cancer.
READ FULL ARTICLE From Internetmedicine
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs